In silico structural characterization of Mycobacterium tuberculosis H37Rv UDP-N-acetylmuramate dehydrogenase

International Journal of Integrative Biology

Volumn 6, Issue 1, 2009, Pages 12-16

  Babajan, B ^a   Anuradha, C M ^a   Chaitanya, M ^a   Gowsia, D ^a   Kumar, Chitta Suresh ^a  

^a SRI KRISHNADEVARAYA UNIVERSITY   (India)

Author keywords

AutoDock4; Homology modeling; MotifScan; Mtb MurB; PDBSUM

Indexed keywords

BACTERIAL ENZYME; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID DEHYDROGENASE;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER MODEL; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; MOLECULAR DOCKING; MYCOBACTERIUM TUBERCULOSIS; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; VALIDITY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 67649565474     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Altschul SF, Grish W, et al. (1990) Basic local alignment search tool. J. Mol.Biol., 215: 403-410.
2. Bateman A, Birney E, et al. (2002) The Pfam Protein Families Database. Nucleic Acids Res., 30: 276-280.
3. Blondal K (2007) Barriers to reaching the targets for tuberculosis control: multidrug resistant tuberculosis, Bull. World Health Organ. 85: 387-390.
4. Chenna R, Sugawana H, et al. (2003) Multiple sequene alignment with the clustal series of program. Nucleic Acids Res. 31: 3497-3500.
5. Goodsell GM, Halliday DS, et al. (1998) Automated docking using a Lamarckian genetic algorithm and an empiricalbinding free energy function, J. Comput. Chem., 19: 1639-1662.
6. Guex NA, Diemand MC, et al. (1999) Protein modelling for all, Trends Biochem. Sci., 24: 364-367.
7. Laskowski RA, Chistyakov VV, et al. (2005) PDBSUM more: new summaries and analyses of the known 3-D structures proteins and nucleic acids. Nucleic Acids Res. 33: D266-D268.
8. Laskowski RA, MacArthur MW, et al. (1993) PROCHECK: a program to check the stereo chemical quality of protein structure. J. Appl. Cryst. 26: 283-291.
9. Mengin-Lecreulx D, Flouret B, et al. (1982) Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli. J. Bacteriol. 151: 1109-1117.
10. Sali A (1995) Comparative protein modeling by satisfaction of spatial restraints. Molecular Medicine Today 1: 270-277
11. Sali A, Shakhnovich EI, et al. (1994) How does a protein fold? Nature 369: 248-251.
12. Sharmila, A, Mrudula P, et al. (2005) Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysisî. J. Comp. Bio.l and Chem. 29(5): 368-78.
13. Sippl MJ (1993) Recognition of errors in three-dimensional structures in proteins, Proteins 17: 355-362.
14. Vriend G (1990) WHAT IF: a molecular modeling and drug design program. J. Mol. Graphics 8(1): 52-56.
15. Walker D, Maher B, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic, Arch. Intern. Med. 163: 1009-1021.
16. World Health Organisation (2008) Tuberculosis. Fact sheet 104. http://www.who.int/tb/publications/2008/factsheet_april08.pdf
17. Zoeiby El., Sanschagrin F, et al. (2003) Structure and function of the Mur enzymes: development of novel inhibitors, Mol. Microbiol. 47: 1-12